Gastrointestinal findings linked to autism were first noted by Dr. Andrew Wakefield post-MMR vaccine, sparking interest in microbiome interventions for autism. ASD now affects 1 in 33 children, increasing with more routine vaccines.
Update on the Microbiome as a Therapeutic Target in Autism Research Exploding on the Gut-Brain Connection Sun, 12 Jan 2025 10:11:55 GMT https://petermcculloughmd.substack.com/p/update-on-the-microbiome-as-a-therapeutic By Peter A. McCullough, MD, MPH
Ever since the seminal paper on gastrointestinal findings and autism was published by Dr. Andrew Wakefield in children who had received the MMR vaccine, there has been a growing interest in gastrointestinal symptoms and interventions that target the microbiome in the treatment of autism. Autism spectrum disorder (ASD) now affects 1 and 33 children and is becoming more common every day as the number of routine vaccines continues to expand for young children.
Moreno RJ, Ashwood P. An Update on Microbial Interventions in Autism Spectrum Disorder with Gastrointestinal Symptoms. Int J Mol Sci. 2024 Dec 5;25(23):13078. doi: 10.3390/ijms252313078. PMID: 39684788; PMCID: PMC11641496.
Subscribe now
Read more